Profiling the genome and proteome of metabolic dysfunction-associated steatotic liver disease identifies potential therapeutic targets
通过对代谢功能障碍相关脂肪肝疾病的基因组和蛋白质组进行分析,可以识别潜在的治疗靶点。
期刊:
影响因子:
doi:10.1101/2023.11.30.23299247
Liu, Jun; Hu, Sile; Chen, Lingyan; Daly, Charlotte; Prada Medina, Cesar Augusto; Richardson, Tom G; Traylor, Matthew; Dempster, Niall J; Mbasu, Richard; Monfeuga, Thomas; Vujkovic, Marijana; Tsao, Philip S; Lynch, Julie A; Voight, Benjamin F; Chang, Kyong-Mi; Million, V A; Cobbold, Jeremy F; Tomlinson, Jeremy W; van Duijn, Cornelia M; Howson, Joanna M M